InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 215903

Wednesday, 07/29/2015 6:42:04 PM

Wednesday, July 29, 2015 6:42:04 PM

Post# of 345787
Director Michael Molony out at Avid and in at Althea

https://www.linkedin.com/pub/michael-molony/5/7a8/bb5

... Michael left some good words for CJ Dash:

Quality Control Supervisor
Avid Bioservices
July 2012 – May 2015 (2 years 11 months)Orange County, California

(Open)1 recommendation

Michael Molony
Director of Analytical Development, ADCs at Althea, CMO

I worked with CJ at Avid in the QC department. CJ took on the leadership role in resolving several high priority client investigations. The investigations were thorough, accurate and resulted in a satisfied customer. CJ is dedicated, hardworking...View

https://www.linkedin.com/in/cjdash

--------------------------------------------


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News